Resistance to TRK inhibition mediated by convergent MAPK pathway activation. [electronic resource]
Producer: 20191112Description: 1422-1427 p. digitalISSN:- 1546-170X
- Adolescent
- Adult
- Animals
- Benzamides -- administration & dosage
- Cell Proliferation -- drug effects
- Cell-Free Nucleic Acids -- drug effects
- Child
- Clinical Trials as Topic
- Drug Resistance, Neoplasm -- drug effects
- Female
- Heterografts
- Humans
- Imidazoles -- administration & dosage
- Indazoles -- administration & dosage
- MAP Kinase Signaling System -- drug effects
- Male
- Mice
- Mitogen-Activated Protein Kinase Kinases -- antagonists & inhibitors
- Molecular Targeted Therapy
- Neoplasms -- drug therapy
- Oncogene Proteins, Fusion -- genetics
- Oximes -- administration & dosage
- Protein Kinase Inhibitors -- administration & dosage
- Pyrazoles -- administration & dosage
- Pyridones -- administration & dosage
- Pyrimidines -- administration & dosage
- Pyrimidinones -- administration & dosage
- Receptor, trkA -- genetics
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.